RPC4046 is an IL-13 antibody that was evaluated in a phase 2 clinical trial
Addressing and treating any underlying medical causes of weight gain/poor weight control is essential
Semaglutide Common side effects may include: Nausea Vomiting Diarrhea Abdominal pain Constipation Heartburn Burping More severe side effects that require immediate medical attention: Ongoing upper stomach pain (with or without vomiting) Rash, itching, or swelling of the eyes, face, mouth, tongue, or throat Difficulty breathing or swallowing Decreased urination or swelling of legs, ankles, or feet Vision changes Fainting or dizziness Rapid heartbeat, anxiety, mood changes, or confusion Semaglutide may affect mental health, leading to symptoms such as depression or suicidal thoughts
This does not necessarily mean GLP-1 therapy is inappropriate, but it does often mean symptoms should be monitored more closely
JAMA 302 , 14441450 (2009)
Also enjoy as a post workout recovery drink